3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Completed
2
Sponsor Class
OTHER
37
INDUSTRY
4
NIH
2
Study Type
Interventional
46
Observational
4
Expanded_access
2
Sponsor
Cancer Type
Genitourinary
3
Gastrointestinal
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
468
Neoplasms
316
Carcinoma, Non-Small-Cell Lung
269
Prostatic Neoplasms
215
Colorectal Neoplasms
208
Lung Neoplasms
178
Multiple Myeloma
123
Melanoma
110
Carcinoma, Renal Cell
107
Ovarian Neoplasms
94
Carcinoma, Hepatocellular
78
Pancreatic Neoplasms
69
Urinary Bladder Neoplasms
65
Stomach Neoplasms
64
Neoplasm Metastasis
64
Leukemia, Lymphocytic, Chronic, B-Cell
62
Colonic Neoplasms
60
Leukemia, Myeloid, Acute
53
Uterine Cervical Neoplasms
50
Recurrence
49
Liver Neoplasms
46
Lymphoma, Follicular
45
Lymphoma
45
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
39
Esophageal Neoplasms
37
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
Lymphoma, Large B-Cell, Diffuse
35
Hematologic Neoplasms
35
Head and Neck Neoplasms
35
Lymphoma, Non-Hodgkin
34
Interventions
Tinzaparin
1
Sunitinib
1
Mitomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
INDUSTRY
×
Observational
×
Urogenital Neoplasms
×
Clear all
NCT05406167
2025-08-15
PREMIER
RefleXion Medical
Recruiting
500 enrolled
NCT05874921
2025-02-28
uTRACT
UroGen Pharma Ltd.
Recruiting
400 enrolled
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled
NCT00460798
2010-11-16
SUNIKA
Pfizer
Completed
356 enrolled
8 charts